000048463 000__ 01478cam\a22003975i\4500
000048463 001__ 48463
000048463 003__ SzGeWIPO
000048463 005__ 20240708150406.0
000048463 006__ m\\\\eo\\d\\\\\\\\
000048463 007__ cr bn |||m|||a
000048463 008__ 230720s2023    nyu|||||o|||||000|0 eng|d
000048463 035__ $$a(OCoLC)1393693924
000048463 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000048463 041__ $$aeng
000048463 24500 $$aFrance: Janssen-Cilag and Johnson & Johnson.
000048463 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2023
000048463 300__ $$a1 online resource
000048463 336__ $$atext$$2rdacontent
000048463 337__ $$acomputer$$2rdamedia
000048463 338__ $$aonline resource$$bcr$$2rdacarrier
000048463 4901_ $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 1
000048463 542__ $$fhttps://1.next.westlaw.com/Copyright
000048463 588__ $$aCrossref
000048463 590__ $$aPublished online: 2023
000048463 650_0 $$aIntellectual property.$$zFrance.
000048463 650_0 $$aCompetition law$$zEuropean Union.
000048463 650_0 $$aPharmaceuticals.
000048463 650_0 $$aGeneric drugs.
000048463 650_0 $$aIntellectual property.
000048463 650_0 $$aCivil law.
000048463 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000048463 7731_ $$wIIC
000048463 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 1.
000048463 85641 $$uhttps://www.westlaw.com/Document/IE11CBE30A68211EDBE2AAFDDE3E5A0BC/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000048463 904__ $$aJournal article
000048463 980__ $$aIIC